Jacek Adam Tuszynski

Full Professor (L. 240)
Department of Mechanical and Aerospace Engineering (DIMEAS)

  • Member of Interdepartmental Center PolitoBIOMed Lab - Biomedical Engineering Lab

Profile

Research interests

Bioelectricita
Cancer chemotherapy
Microtubules
Motor proteins
Pharmacokinetics
Rational drug design
Tubulina

Biography

Affiliations: -Professore Ordinario (P/T), DIMEAS, Politecnico di Torino - Full Professor, Department of Physics, University of Alberta. - Adjunct Professor, Department of Medical Microbiology and Immunology, University of Alberta. - Adjunct Professor, Department of Biomedical Engineering. - Adjunct Professor, Department of Oncology, Division of Medical Physics. Professor Jack Tuszynski obtained his Ph.D. in condensed matter physics in 1983 from the University of Calgary. From 1983 to 1988 he was a faculty member at the Department of Physics of the Memorial University of Newfoundland in St. John’s. He moved to the University of Alberta in 1988 as an assistant professor, between 1990 to 1993 he was an associate and then full professor at the Department of Physics. Between 2005 and 2020 he held the prestigious Allard Chair in Experimental Oncology at the Cross Cancer Institute where he leads an interdisciplinary computational drug discovery group. He is also a Fellow of the National Institute for Nanotechnology of Canada. Dr. Tuszynski held visiting professorship and research positions in China, Germany, France, Israel, Denmark, Belgium and Switzerland. He has published over 500 peer-reviewed journal papers, and 12 books. He delivered almost 400 scientific talks at conferences on five continents, half of which were invited presentations. He submitted 15 reports of invention, 21 patent applications and obtained 4 patents in the USA, South Korea, Japan and Singapore. His research has been supported by over 100 research grants from Canadian, US and European funding agencies. He is on the editorial board of almost 30 international journals including the Journal of Biological Physics. He is an Associate Editor of The Frontiers Collection, Springer-Verlag, Heidelberg. The major thrust of the computational biophysics group is in silico drug design for cancer chemotherapy applications and in vitro testing.

Scientific branch

IBIO-01/A - Bioengineering
(Area 0009 - Industrial and information engineering)

Skills

ERC sectors

LS1_8 - Biophysics (e.g. transport mechanisms, bioenergetics, fluorescence)
PE8_13 - Industrial bioengineering
LS7_3 - Pharmacology, pharmacogenomics, drug discovery and design, drug therapy

Teaching

Collegi of the degree programmes

Teachings

Master of Science

MostraNascondi A.A. passati

Research

Research groups

Research projects

Projects funded by competitive calls

Supervised PhD students

Publications

Latest publications View all publications in Porto@Iris